Related Experiment Videos

[Clinical evaluation of arteriosclerosis using high sensitive CRP in multiphasic screening]

Yoko Tonari1, Tomiko Koyama, Kensuke Saitoh

  • 1Iwate Health Service Association, Morioka 020-8585.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|October 14, 2004
PubMed

Insights

High-sensitivity C-reactive protein (hsCRP) indicates chronic inflammation. Continuous elevated hsCRP strongly predicts acute myocardial infarction (AMI) risk, but not stroke risk.

Area of Science:

  • Biomarkers and Disease Prediction
  • Inflammation and Cardiovascular Disease

Context:

  • Chronic inflammation is a critical factor in various diseases.
  • High-sensitivity C-reactive protein (hsCRP) is a key inflammatory marker.
  • Distinguishing disease-specific risks associated with inflammation is crucial.

Purpose:

  • To evaluate the utility of hsCRP measurements in identifying chronic inflammation.
  • To assess the predictive value of hsCRP for acute myocardial infarction (AMI) and stroke.
  • To compare the relative risks of AMI and stroke in patients with elevated hsCRP.

Summary:

  • Continuous elevated hsCRP levels (average >0.15mg/dl) signal chronic inflammation.
  • hsCRP demonstrated the highest Area Under Curve (AUC) for predicting AMI.
  • Elevated hsCRP showed a 20-fold increased relative risk for AMI, but less than 1-fold for stroke.

Impact:

  • hsCRP is a valuable predictor for acute myocardial infarction (AMI) risk.
  • Blood pressure is a more significant predictor for stroke risk.
  • These findings highlight distinct pathophysiological roles of inflammation in AMI versus stroke.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...